Related Experiment Video
Updated: Jun 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Potential roles for cellular cofactors in hepatitis C virus replication complex formation
Kristi L Berger1, Glenn Randall
1Department of Microbiology; The University of Chicago, Chicago, IL, USA.
Abstract:
Over 130 million people worldwide are chronically infected with hepatitis C virus (HCV). New antiviral treatment strategies are needed due to limitations with current therapy. The identification of cellular cofactors of infection has the potential to broadly expand our therapeutic targets. We recently reported an RNA interference screen of host membrane trafficking genes in HCV infection and replication and identified several cellular co-factors for viral replication. Phosphatidylinositol 4-kinase III alpha (PI4K-IIIalpha) was found to be essential for HCV replication. PI4K-IIIalpha co-localized with viral replication markers. Silencing of PI4K-IIIalpha by siRNAs prior to HCV infection prevented rearrangement of intracellular membranes associated with viral replication complexes, termed the membranous web. Our data suggest that PI4K-IIIalpha is involved in establishing HCV replication complexes, however the mechanism is unknown. From our analysis, along with several other studies that have identified cellular cofactors for HCV replication, we propose that PI4K-IIIalpha may nucleate replication complex formation by facilitating the interaction of viral and/or cellular proteins with cellular membrane-associated phospholipids.
Insights
Hepatitis C virus (HCV) replication requires phosphatidylinositol 4-kinase III alpha (PI4K-IIIalpha). Targeting PI4K-IIIalpha may offer new antiviral strategies against chronic HCV infection.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Hepatitis C virus (HCV) chronically infects over 130 million people globally.
- Current HCV therapies have limitations, necessitating novel antiviral strategies.
- Identifying host cellular cofactors is crucial for expanding therapeutic targets.
Purpose of the Study:
- To investigate the role of host cellular cofactors in hepatitis C virus (HCV) replication.
- To identify specific host genes essential for HCV infection and replication.
- To elucidate the mechanism by which phosphatidylinositol 4-kinase III alpha (PI4K-IIIalpha) contributes to HCV replication.
Main Methods:
- Conducted an RNA interference screen of host membrane trafficking genes in HCV infection.
- Utilized small interfering RNAs (siRNAs) to silence PI4K-IIIalpha expression.
- Examined the co-localization of PI4K-IIIalpha with viral replication markers.
- Assessed the impact of PI4K-IIIalpha silencing on the formation of the membranous web, a hallmark of HCV replication.
Main Results:
- Identified phosphatidylinositol 4-kinase III alpha (PI4K-IIIalpha) as essential for HCV replication.
- Demonstrated that PI4K-IIIalpha co-localizes with viral replication markers.
- Showed that silencing PI4K-IIIalpha prevents the formation of the membranous web, crucial for viral replication complexes.
- Observed that PI4K-IIIalpha is involved in establishing HCV replication complexes.
Conclusions:
- Phosphatidylinositol 4-kinase III alpha (PI4K-IIIalpha) plays a critical role in establishing hepatitis C virus (HCV) replication complexes.
- PI4K-IIIalpha may nucleate replication complex formation by mediating protein-phospholipid interactions at cellular membranes.
- Targeting PI4K-IIIalpha represents a potential therapeutic strategy for developing new antiviral treatments for HCV.
Related Concept Videos
Hepatitis
Cofactors and Coenzymes
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

